These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2018379

  • 21. Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro.
    Zhang P, Gao WY, Turner S, Ducatman BS.
    Mol Cancer; 2003 Jan 03; 2():1. PubMed ID: 12537587
    [Abstract] [Full Text] [Related]

  • 22. Enhancement of radiation response of prostatic carcinoma by lonidamine.
    Dudak SD, Lopez A, Block NL, Lokeshwar BL.
    Anticancer Res; 1996 Jan 03; 16(6B):3665-71. PubMed ID: 9042239
    [Abstract] [Full Text] [Related]

  • 23. A study of various strategies to enhance the cytotoxic activity of 5-fluorouracil/leucovorin in human colorectal cancer cell lines.
    Scheithauer W, Temsch EM.
    Anticancer Res; 1989 Jan 03; 9(6):1793-8. PubMed ID: 2627128
    [Abstract] [Full Text] [Related]

  • 24. Cytotoxic effect of the association of BCNU with rhein or lonidamine on a human glioma cell line.
    Floridi A, Gentile PF, Bruno T, Fanciulli M, Paggi MG, Zeuli M, Benassi M.
    Anticancer Res; 1991 Jan 03; 11(2):789-92. PubMed ID: 1648334
    [Abstract] [Full Text] [Related]

  • 25. The role of tamoxifen in combination with cisplatin on oral squamous cell carcinoma cell lines.
    Kim MJ, Lee JH, Kim YK, Myoung H, Yun PY.
    Cancer Lett; 2007 Jan 08; 245(1-2):284-92. PubMed ID: 16513256
    [Abstract] [Full Text] [Related]

  • 26. [The enhancement of the chemotherapeutic effects on human prostate cancer cell--the combination with the growth factor interaction inhibitor (suramin)].
    Suzuki Y, Miwa Y, Akino H, Fujita T, Saikawa S, Kanimoto Y, Okada K.
    Hinyokika Kiyo; 1993 Dec 08; 39(12):1215-20. PubMed ID: 8285172
    [Abstract] [Full Text] [Related]

  • 27. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH, Song YC, Kim SH, Jo H, Song YS.
    Ann N Y Acad Sci; 2009 Aug 08; 1171():642-8. PubMed ID: 19723115
    [Abstract] [Full Text] [Related]

  • 28. Effectiveness of cis-platin and carboplatin in the chemotherapy of squamous cell carcinoma grown as multicellular spheroids.
    Schwachöfer JH, Crooijmans RP, Hoogenhout J, Kal HB, Theeuwes AG.
    Anticancer Res; 1990 Aug 08; 10(3):805-11. PubMed ID: 2195988
    [Abstract] [Full Text] [Related]

  • 29. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
    Peters RH, Jollow DJ, Stuart RK.
    Cancer Res; 1991 May 15; 51(10):2536-41. PubMed ID: 2021933
    [Abstract] [Full Text] [Related]

  • 30. In vitro potentiation by lonidamine of the sc-RIP saporin 6 effect in a human metastatic breast cancer cell line.
    Roncuzzi L, Zoli W, Bajorko P, Gasperi-Campani A.
    Anticancer Res; 1995 May 15; 15(3):773-6. PubMed ID: 7645957
    [Abstract] [Full Text] [Related]

  • 31. Cisplatin-controlled p53 gene therapy for human non-small cell lung cancer xenografts in athymic nude mice via the CArG elements.
    Wang WD, Li R, Chen ZT, Li DZ, Duan YZ, Cao ZH.
    Cancer Sci; 2005 Oct 15; 96(10):706-12. PubMed ID: 16232203
    [Abstract] [Full Text] [Related]

  • 32. Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines.
    Hoffmann T, Hafner D, Ballo H, Haas I, Bier H.
    Anticancer Res; 1997 Oct 15; 17(6D):4419-25. PubMed ID: 9494544
    [Abstract] [Full Text] [Related]

  • 33. In vitro cytotoxic dose-relation of cisplatin and sodium thiosulphate in human tongue and oesophageal squamous carcinoma cell lines.
    Kovács AF, Cinatl J.
    J Craniomaxillofac Surg; 2002 Feb 15; 30(1):54-8. PubMed ID: 12064884
    [Abstract] [Full Text] [Related]

  • 34. Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro.
    Rosbe KW, Brann TW, Holden SA, Teicher BA, Frei E.
    Cancer Chemother Pharmacol; 1989 Feb 15; 25(1):32-6. PubMed ID: 2590999
    [Abstract] [Full Text] [Related]

  • 35. The cytoskeleton as a subcellular target of the antineoplastic drug lonidamine.
    Malorni W, Meschini S, Matarrese P, Arancia G.
    Anticancer Res; 1992 Feb 15; 12(6B):2037-45. PubMed ID: 1295447
    [Abstract] [Full Text] [Related]

  • 36. Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts.
    De Cesare M, Pratesi G, Giusti A, Polizzi D, Zunino F.
    Br J Cancer; 1998 Feb 15; 77(3):434-9. PubMed ID: 9472640
    [Abstract] [Full Text] [Related]

  • 37. Combined effects of lonidamine and hyperthermia on malignant melanoma and lung carcinoma surgical specimens.
    Zaffaroni N, Villa R, Orlandi L, Vaglini M, Silvestrini R.
    Anticancer Res; 1992 Feb 15; 12(1):247-50. PubMed ID: 1314533
    [Abstract] [Full Text] [Related]

  • 38. In vitro potentiation by lonidamine of the cytotoxic effect of adriamycin on primary and established breast cancer cell lines.
    Savini S, Zoli W, Nanni O, Volpi A, Frassineti GL, Magni E, Flamigni A, Amadori A, Amadori D.
    Breast Cancer Res Treat; 1992 Feb 15; 24(1):27-34. PubMed ID: 1463869
    [Abstract] [Full Text] [Related]

  • 39. Modulation of alkylating agents by lonidamine in vivo.
    Teicher BA, Holden SA, Herman TS, Frei E.
    Semin Oncol; 1991 Apr 15; 18(2 Suppl 4):7-10. PubMed ID: 1903216
    [Abstract] [Full Text] [Related]

  • 40. Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro.
    Raitanen M, Rantanen V, Kulmala J, Helenius H, Grénman R, Grénman S.
    Int J Cancer; 2002 Jul 10; 100(2):238-43. PubMed ID: 12115575
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.